This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.
Get full access to this article
View all access options for this article.
References
1.
TeunissenC.E.DijkstraC.D.PolmanC.H.HoogervorstE.L.von BergmannK.LutjohannD.Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients. Neurosci Lett.2003; 347: 159–162.
2.
StuveO.YoussefS.SteinmanL.ZamvilS.S.Statins as potential therapeutic agents in neuroinflammatory disorders. Curr Opin Neurol.2003; 16: 393–401.
3.
NeuhausO.Strasser-FuchsS.FazekasF.Statins as immunomodulators: Comparison with interferon-beta 1b in MS. Neurology.2002; 59: 990–997.
BirnbaumG.CreeB.AltafullahI.ZinserM.RederA.T.Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. Neurology.2008; 71(18): 1390–1395.
6.
KammC.P.El-KoussyM.HumpertS.Atorvastatin added to interferon-β for relapsing multiple sclerosis: A randomized controlled trial. J Neurol.2012; 259(11): 2401–2413.
7.
LanzilloR.OreficeG.QuarantelliM.Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: A longitudinal controlled trial of combination therapy. Mult Scler.2010; 16(4): 450–454.
8.
BhardwajS.ColemanC.I.SobierajD.M.Efficacy of statins in combination with interferon therapy in multiple sclerosis: A meta-analysis. Am J Health Syst Pharm.2012; 69(17): 1494–1499.
9.
WangJ.XiaoY.LuoM.LuoH.Statins for multiple sclerosis. Cochrane Database Syst Rev.2011; (12): CD008386
